Invention Grant
- Patent Title: Anti-CLDN-5 antibody, and drug containing said antibody
-
Application No.: US16611678Application Date: 2018-04-26
-
Publication No.: US11053313B2Publication Date: 2021-07-06
- Inventor: Masuo Kondoh , Kiyohito Yagi , Takefumi Doi , Yoshiaki Okada , Yosuke Hashimoto , Tatsuya Sawasaki , Hiroyuki Takeda , Kohki Endo , Maki Tamura
- Applicant: OSAKA UNIVERSITY , NATIONAL UNIVERSITY CORPORATION EHIME UNIVERSITY , FUJIFILM Wako Pure Chemical Corporation
- Applicant Address: JP Osaka; JP Ehime; JP Osaka
- Assignee: OSAKA UNIVERSITY,NATIONAL UNIVERSITY CORPORATION EHIME UNIVERSITY,FUJIFILM Wako Pure Chemical Corporation
- Current Assignee: OSAKA UNIVERSITY,NATIONAL UNIVERSITY CORPORATION EHIME UNIVERSITY,FUJIFILM Wako Pure Chemical Corporation
- Current Assignee Address: JP Osaka; JP Ehime; JP Osaka
- Agency: Wenderoth, Lind & Ponack, L.L.P.
- Priority: JPJP2017-092658 20170508
- International Application: PCT/JP2018/016975 WO 20180426
- International Announcement: WO2018/207638 WO 20181115
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/18 ; C07K16/28
Abstract:
An object of the present invention is to provide a novel molecule which has high specificity to CLDN-5 and recognizes an extracellular domain of CLDN-5. The object is achieved by an antibody which specifically recognizes a three-dimensional structure or a primary structure of an extracellular domain of a Claudin-5 protein.
Public/Granted literature
- US20200148765A1 ANTI-CLDN-5 ANTIBODY, AND DRUG CONTAINING SAID ANTIBODY Public/Granted day:2020-05-14
Information query
